Showing results (231-240 of 239) with videos related to
Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 239 results.
The International Journal of Cardiovascular Imaging|October 25, 2017
High T2-weighted signal intensity for risk prediction of sudden cardiac death in hypertrophic cardiomyopathyD H Frank Gommans, G Etienne Cramer, Jeannette Bakker, et al.The American Journal of Cardiology|September 12, 2018
Prediction of Extensive Myocardial Fibrosis in Nonhigh Risk Patients With Hypertrophic CardiomyopathyD H Frank Gommans, G Etienne Cramer, Michael A Fouraux, et al.Medicine and Science in Sports and Exercise|April 30, 2019
Association between Lifelong Physical Activity and Disease Characteristics in HCMVincent L Aengevaeren, D H Frank Gommans, Hendrik-Jan Dieker, et al.Journal of Cardiac Failure|June 15, 2022
Fluid REStriction in Heart Failure vs Liberal Fluid UPtake: Rationale and Design of the Randomized FRESH-UP StudyJob J Herrmann, Fabienne Beckers-Wesche, Lisette E H J M Baltussen, et al.JAMA Cardiology|November 18, 2019
Effect of Face-to-Face vs Virtual Reality Training on Cardiopulmonary Resuscitation Quality: A Randomized Clinical TrialJoris Nas, Jos Thannhauser, Priya Vart, et al.ESC Heart Failure|July 29, 2026
The Effect of a Change in Fluid Intake Advice on Outcomes in Chronic Heart Failure: A prespecified subanalysis of the FRESH-UP StudyJob J Herrmann, Hans-Peter Brunner La Rocca, Lisette E H J M Baltussen, et al.Nature Medicine|March 30, 2025
Liberal fluid intake versus fluid restriction in chronic heart failure: a randomized clinical trialJob J Herrmann, Hans-Peter Brunner-La Rocca, Lisette E H J M Baltussen, et al.Journal of the American Heart Association|August 24, 2022
Renin-Angiotensin System Inhibitors in Patients With COVID-19: A Meta-Analysis of Randomized Controlled Trials Led by the International Society of HypertensionSonali R Gnanenthiran, Claudio Borghi, Dylan Burger, et al.American Heart Journal|June 9, 2020
Rationale and design of the PRAETORIAN-COVID trial: A double-blind, placebo-controlled randomized clinical trial with valsartan for PRevention of Acute rEspiraTORy dIstress syndrome in hospitAlized patieNts with SARS-COV-2 Infection DiseaseD H Frank Gommans, Joris Nas, Sara-Joan Pinto-Sietsma, et al.Pageof 24